WOCKPHARMANSEWockhardt Limited· PharmaceuticalsMediumNeutral
Announced Tue, 30 Jun · 12:50 IST

Wockhardt files disclosure on encumbered shares under Takeover Regulations

Ownership Changes View source PDF

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹1950.00
prior close
₹1940.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2-0.2-0.2+0.9+0.1-0.5-1.7-4.9-5.9-3.0
Up moveDown movePending
AI summary

Wockhardt Limited has submitted to NSE a disclosure under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation typically requires promoters to disclose details of shares that have been pledged or encumbered. The filing itself does not specify the nature or size of the encumbrance or any change in it.

Likely market impact

Routine regulatory disclosure; details on pledged shares not provided in this filing, so limited immediate impact on investors.